In Being Patient’s LiveTalk series, scientist Ed Blonz discusses the role of glucose in maintaining brain function, and why tackling the brain’s energy deficiency…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
In Being Patient’s LiveTalk series, a scientist explores the biology of the blood-brain barrier — the brain’s layer of protection against pathogens and toxins…
Growing evidence shows that hearing loss is the leading controllable risk factor in midlife for dementia. Danielle Powell, an audiologist and epidemiologist at Johns…
To understand memory, we must understand the power and vulnerability of the brain. In Being Patient’s LiveTalk series, Lisa Genova, neuroscientist and author of Remember,…
For the retired neurologist Daniel Gibbs, a diagnosis of early-stage Alzheimer’s not only gave him a sense of relief, but also a clear path…
Following the FDA’s approval of the new Alzheimer’s drug Aduhelm (aducanumab), retired neurologist Daniel Gibbs spoke with Being Patient in a recent LiveTalk about…